en
Fespixon® is not approved by the U.S. FDA. This website is intended for international healthcare professionals outside the U.S. only.
en
Fespixon® is not approved by the U.S. FDA. This website is intended for international healthcare professionals outside the U.S. only.

Knowledge

Education

“The Hidden Worries Below”: Analyzing Diabetic Foot Ulcers and Their Grading

Diabetes is a chronic metabolic disease that affects over 500 million people worldwide, who also suffer from its complications such as vascular and neuropathic disorders. Among these, Diabetic Foot Ulcer (DFU) is one of the most common lower limb complications, with up to 19%-34% (approximately one quarter) of diabetic patients likely to experience “Diabetic Foot Ulcers” at some point in their lives2. This article will delve into the basic knowledge and introduction of diabetic foot ulcers, as well as the mainstream wound classification systems.
Read More

Self-Check: A Home Inspection Guide for Diabetic Foot Symptoms

The common symptoms of diabetic foot are as follows. If patients with diabetes experience the following symptoms, please seek advice from medical professionals or seek medical help promptly.
Read More

The Global Status and Recurrence of Diabetic Foot Ulcers

There are over 500 million people with diabetes globally, and approximately 18 million are at risk of developing 'Diabetic Foot Ulcers' each year. Remarkably, up to 34% of individuals with diabetes may experience DFU during their lifetime. Remarkably, up to 34% of individuals with diabetes may experience DFU during their lifetime.
Read More
1 2 3 4
Training

Treatment of Diabetic Foot Ulcers

The treatment process for diabetic foot is extremely complex and requires collaboration across multidisciplinary team members.
Read More

Daily Care of Diabetic Foot Ulcers

To effectively prevent the occurrence of foot ulcers, it is essential to engage in proper foot care, undergo regular examinations, and address arterial hardening.
Read More